Home›Stock Screener›RPG Life Sciences

RPG Life Sciences Share Price Today | Stock Price & RPG Life Sciences Share Screener

RPGLIFE Pharmaceuticals
Live Share Price NSE
₹2896.40
▼ -34.30 (-1.17%)
2026-10-05 00:00:00
Live Share Price BSE
₹2892.40
▼ -44.35 (-1.51%)
2026-10-05 00:00:00

As of October 5, 2026, the live RPG Life Sciences share price (NSE: RPGLIFE) is ₹2,896.40 on NSE and ₹2,892.40 on BSE, down 1.17% from the previous close, with shares trading between ₹2,832.60 and ₹2,983.50 in today's trading session, and a 52-week range of ₹1,744.00–₹3,089.20. Check RPGLIFE 52-week chart for the annual price range and momentum. Use the RPG Life Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today RPG Life Sciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹190 and net income of ₹30, with EBITDA of ₹46, an operating margin of 19.0% and a profit margin of 15.8%.

RPG Life Sciences Market Cap ₹4,887.44 Cr.
RPGLIFE P/E Ratio (TTM) 41.97
RPG Life Sciences P/B Ratio 8.30
EPS (TTM) ₹69.64
Dividend Yield 0.79%
Debt to Equity 0.02
RPGLIFE 52 Week High ₹3089.20
RPG Life Sciences 52 Week Low ₹1744.00
Operating Margin 19.00%
Profit Margin 15.79%
RPGLIFE Revenue (TTM) ₹190.00
EBITDA ₹46.00
Net Income ₹30.00
Total Assets ₹793.00
Total Equity ₹605.00

RPG Life Sciences Share Price Chart

Track the current stock price of RPG Life Sciences with an interactive chart. Analyse RPGLIFE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete RPG Life Sciences stock quote in one place.

The quote of ₹2,896.40 sits between the 52-week low of ₹1,744.00 and the 52-week high of ₹3,089.20, and the latest session moved -1.17% from the previous close.

RPG Life Sciences Company Profile - Fundamental Screener

Screen RPG Life Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for RPGLIFE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE105J01010.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE105J01010

RPG Life Sciences Balance Sheet Screener

Screen RPGLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹793, up from ₹658 in 2025.

Latest statistics put total assets at ₹793 and shareholder funds at ₹605, with a leverage ratio of 0.02.

Item 2026 2025

Assets

Total Assets 793 658
Current Assets 560 465
Fixed Assets 197 172

Liabilities

Total Liabilities 0 0
Current Liabilities 27 7
Non-Current Liabilities 0 0

Shareholders' Equity

Total Equity 605 531
Share Capital 13 13
Reserves & Surplus 592 517

RPG Life Sciences Income Statement Screener - Profit & Revenue Analysis

Screen RPG Life Sciences income statement and profit fundamentals. Analyze RPGLIFE quarterly results. RPG Life Sciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹190 and net profit was ₹30, equal to earnings per unit of ₹18.08, at an operating margin of 19%.

In that period expenses were ₹144, interest cost ₹0 and tax ₹10. The next period listed, 2026-Jun, shows revenue of ₹200 and net profit of ₹31.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Dec

Revenue and Expenses

Revenue 190 200 258 174 197 183 176
Expenses 144 152 118 133 143 149 124

Operating Costs and Margins

EBITDA 46 48 140 41 55 35 53
Operating Profit % 19.00% 22.00% 18.00% 21.00% 21.00% 17.00% 28.00%
Depreciation 6 6 5 5 5 5 6
Interest 0 1 0 0 0 0 0

Profit and Earnings

Profit Before Tax 40 42 135 35 50 29 47
Tax 10 11 18 9 13 7 12
Net Profit 30 31 117 26 37 22 35
EPS 18.08 18.60 70.96 15.90 22.28 13.38 21.12

RPG Life Sciences Cash Flow Screener - Liquidity Fundamentals

Screen RPGLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹57, and net cash flow was an inflow of ₹122.

Over the same period, investing activities provided ₹86 and financing activities used ₹21.

Item 2026-March 2025-March

Cash from Operations and Investing

Operating Activities 57 78
Investing Activities 86 -42

Financing and Net Cash

Financing Activities -21 -27
Net Cash Flow 122 9

RPG Life Sciences Shareholding Pattern Screener

See RPG Life Sciences shareholding pattern with promoter, FII, and DII holdings. Check RPG Life Sciences promoter holding and ownership changes for RPGLIFE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 72.95%, foreign institutions 0.87%, domestic institutions 7.45% and the public 14.98%, spread across 25,282 shareholders.

The shareholder count was 25,282 in 2026-Mar, compared with 23,886 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 72.95% 72.95% 72.95% 72.95% 72.95% 72.95% 72.81% 72.81%

Institutional Investors

FII Holding 0.87% 0.95% 1.45% 1.35% 1.11% 1.00% 0.89% 1.14%
DII Holding 7.45% 8.67% 6.14% 6.48% 6.70% 7.04% 4.19% 4.63%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 14.98% 13.88% 15.33% 15.46% 15.37% 15.17% 17.41% 16.79%
Other Holding 3.74% 3.54% 4.12% 3.76% 3.88% 3.83% 4.70% 4.62%
Shareholder Count 25,282 23,886 24,867 25,832 26,657 25,905 22,137 22,232

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by RPG Life Sciences. RPG Life Sciences dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹24.00 per unit for 2026-March, a yield of 0.79%, compared with ₹24.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹24.00, ₹24.00 and ₹16.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹24.00 0.79%
2025-March ₹24.00 1.29%
2024-March ₹16.00 0.70%
2023-March ₹12.00 0.79%
2022-March ₹9.60 1.40%
2021-March ₹7.20 1.28%
2020-March ₹4.00 1.03%
2019-March ₹2.40 1.41%
2018-March ₹2.40 0.97%
2017-March ₹2.80 0.73%

RPG Life Sciences Stock Index Membership - Nifty & Sensex

See which indices include RPG Life Sciences stock. Check RPGLIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 3 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP

RPG Life Sciences Market Events Screener - Corporate Actions

Get RPG Life Sciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check RPG Life Sciences stock events that may affect RPGLIFE share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated July 28, 2026, with a record date of July 28, 2026.

It is followed by Annual General Meeting dated July 23, 2026 and Dividend dated July 9, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-07-28 2026-07-28 Quarterly Result Announcement NA -2.99%
2026-07-23 2026-07-23 Annual General Meeting NA 31.96%
2026-07-09 2026-07-09 Dividend ₹ 24.00 /share 19.40%
2026-04-29 2026-04-29 Quarterly Result Announcement NA 3.00%
2026-01-27 2026-01-27 Quarterly Result Announcement NA -6.97%
2025-10-17 2025-10-17 Quarterly Result Announcement NA 3.21%
2025-07-25 2025-07-25 Quarterly Result Announcement NA -1.32%
2025-07-16 2025-07-16 Annual General Meeting NA 9.20%
2025-06-27 2025-06-27 Dividend ₹ 4.00 /share 8.01%
2025-06-27 2025-06-27 Dividend ₹ 20.00 /share 8.01%
2025-04-28 2025-04-28 Quarterly Result Announcement NA 2.14%
2025-01-24 2025-01-24 Quarterly Result Announcement NA 4.82%
2024-11-07 2024-11-07 Quarterly Result Announcement NA 9.41%
2024-07-16 2024-07-16 Annual General Meeting NA 6.83%
2024-06-28 2024-06-28 Dividend ₹ 16.00 /share 2.52%

RPG Life Sciences Competitors Screener - Peer Stocks Comparison

Screen RPGLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 440,998 36.70 61,674 12.69% 11,565 40.74
Divis Laboratories 253,522 87.22 11,067 13.95% 2,568 63.87
Torrent Pharmaceuticals 185,201 87.95 13,886 20.34% 2,138 46.50
Zydus Life Science 122,257 26.11 27,658 17.64% 5,026 66.57
Cipla 111,782 33.64 29,045 2.24% 3,870 45.42
Laurus Labs 108,549 99.16 6,868 22.01% 890 64.04
Dr Reddys Laboratories 101,913 31.54 35,059 3.90% 4,158 63.11
Mankind Pharma 100,589 49.45 14,636 14.85% 1,938 55.24
Aurobindo Pharma 97,670 26.54 34,145 5.56% 3,503 54.66
Lupin 94,281 17.22 29,039 26.75% 5,356 35.30

RPG Life Sciences Company Announcements - News & Reports Screener

Screen RPGLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated October 2, 2026 and October 2, 2026.

Date Update Actions
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 -
2026-10-02 Intimation For Scheme Of Amalgamation -
2026-10-02 Closure of Trading Window -
2026-10-01 Update On Share Purchase Agreement -
2026-10-01 Clarification For Volume Movement Letter -
2026-10-01 Clarification sought from RPG Life Sciences Ltd -
2026-09-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-15 Update On Business Transfer Agreement By RPGAP -
2026-09-09 Update On Investment And Shareholder Agreement -
2026-09-04 Outcome Of Investors Meet -
2026-09-03 Investors Meet -
2026-09-02 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-09-02 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-02 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-09-02 Intimation Of Execution Of BTA By RPG Active Pharma Limited (WOS) With Raghava Life Sciences Private Limited -
2026-09-02 Outcome Of Board Meeting -
2026-09-01 Cancellation Of Investor Meet -
2026-08-25 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-20 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-15 Announcement under Regulation 30 (LODR)-Cessation -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹2,896.40, within a 52-week range of ₹1,744.00 to ₹3,089.20. The P/E ratio is 41.97 and the P/B ratio is 8.30, with earnings per unit of ₹69.64. Market capitalisation stands at ₹4,887.44 Cr and the dividend yield is 0.79%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 2 balance sheet periods, 7 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.